1. Home
  2. JAGX vs AIHS Comparison

JAGX vs AIHS Comparison

Compare JAGX & AIHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • AIHS
  • Stock Information
  • Founded
  • JAGX 2013
  • AIHS 2014
  • Country
  • JAGX United States
  • AIHS China
  • Employees
  • JAGX N/A
  • AIHS N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • AIHS Finance: Consumer Services
  • Sector
  • JAGX Health Care
  • AIHS Finance
  • Exchange
  • JAGX Nasdaq
  • AIHS Nasdaq
  • Market Cap
  • JAGX 3.4M
  • AIHS 3.0M
  • IPO Year
  • JAGX N/A
  • AIHS 2018
  • Fundamental
  • Price
  • JAGX $2.35
  • AIHS $2.20
  • Analyst Decision
  • JAGX Strong Buy
  • AIHS
  • Analyst Count
  • JAGX 1
  • AIHS 0
  • Target Price
  • JAGX $60.00
  • AIHS N/A
  • AVG Volume (30 Days)
  • JAGX 75.4K
  • AIHS 46.0K
  • Earning Date
  • JAGX 08-14-2025
  • AIHS 08-26-2025
  • Dividend Yield
  • JAGX N/A
  • AIHS N/A
  • EPS Growth
  • JAGX N/A
  • AIHS N/A
  • EPS
  • JAGX N/A
  • AIHS N/A
  • Revenue
  • JAGX $11,552,000.00
  • AIHS $3,389,072.00
  • Revenue This Year
  • JAGX $22.41
  • AIHS N/A
  • Revenue Next Year
  • JAGX $30.00
  • AIHS N/A
  • P/E Ratio
  • JAGX N/A
  • AIHS N/A
  • Revenue Growth
  • JAGX 13.93
  • AIHS N/A
  • 52 Week Low
  • JAGX $1.93
  • AIHS $2.10
  • 52 Week High
  • JAGX $35.25
  • AIHS $17.00
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 46.26
  • AIHS 29.64
  • Support Level
  • JAGX $2.02
  • AIHS $2.10
  • Resistance Level
  • JAGX $2.33
  • AIHS $2.74
  • Average True Range (ATR)
  • JAGX 0.14
  • AIHS 0.30
  • MACD
  • JAGX 0.07
  • AIHS 0.06
  • Stochastic Oscillator
  • JAGX 58.33
  • AIHS 8.70

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About AIHS Senmiao Technology Limited

Senmiao Technology Ltd is a holding company. Along with its subsidiaries, it is engaged in facilitating automobile transactions and offering related services. The group's business activities include providing car rental services to individual customers with lease term no more than twelve months; leasing and servicing of new energy vehicles; offering services to automobile purchasers throughout the purchase process; providing management and related services to Partner Platforms and other companies; automobile financing; and providing other related supporting services to customers. The majority of the group's revenue is generated from its automobile rental business.

Share on Social Networks: